IRIS
DELLA TORRE, EMANUEL
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.360
NA - Nord America 4.660
AS - Asia 4.441
SA - Sud America 1.172
Continente sconosciuto - Info sul continente non disponibili 313
AF - Africa 99
OC - Oceania 40
Totale 16.085
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.321
RU - Federazione Russa 2.523
SG - Singapore 1.467
CN - Cina 1.463
IT - Italia 1.411
BR - Brasile 945
HK - Hong Kong 530
SE - Svezia 517
VN - Vietnam 434
FR - Francia 219
DE - Germania 168
BD - Bangladesh 161
CA - Canada 146
GB - Regno Unito 141
FI - Finlandia 94
AR - Argentina 76
IN - India 72
MX - Messico 61
NL - Olanda 59
ID - Indonesia 42
JP - Giappone 42
ES - Italia 40
TR - Turchia 39
AT - Austria 37
PL - Polonia 37
CO - Colombia 35
ZA - Sudafrica 35
AU - Australia 33
EC - Ecuador 32
IQ - Iraq 32
CR - Costa Rica 26
PY - Paraguay 25
PK - Pakistan 22
IE - Irlanda 20
JM - Giamaica 20
UA - Ucraina 20
VE - Venezuela 18
CL - Cile 16
HN - Honduras 16
MY - Malesia 16
PE - Perù 16
MA - Marocco 14
PH - Filippine 14
EG - Egitto 13
GT - Guatemala 13
SV - El Salvador 12
RO - Romania 11
SA - Arabia Saudita 11
TN - Tunisia 11
TT - Trinidad e Tobago 11
UZ - Uzbekistan 11
AE - Emirati Arabi Uniti 10
IL - Israele 10
IR - Iran 10
KE - Kenya 10
BE - Belgio 9
CH - Svizzera 9
JO - Giordania 9
LT - Lituania 9
GP - Guadalupe 8
NI - Nicaragua 7
NP - Nepal 7
NZ - Nuova Zelanda 7
CW - ???statistics.table.value.countryCode.CW??? 6
DO - Repubblica Dominicana 6
DZ - Algeria 6
HU - Ungheria 6
KZ - Kazakistan 5
TH - Thailandia 5
UY - Uruguay 5
AL - Albania 4
CY - Cipro 4
HT - Haiti 4
KR - Corea 4
LB - Libano 4
LV - Lettonia 4
PT - Portogallo 4
BH - Bahrain 3
BO - Bolivia 3
CZ - Repubblica Ceca 3
GR - Grecia 3
MD - Moldavia 3
PR - Porto Rico 3
SC - Seychelles 3
TW - Taiwan 3
AZ - Azerbaigian 2
CG - Congo 2
DM - Dominica 2
EE - Estonia 2
EU - Europa 2
HR - Croazia 2
MQ - Martinica 2
PS - Palestinian Territory 2
AM - Armenia 1
BG - Bulgaria 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
ET - Etiopia 1
Totale 15.767
Salva come PNG Salva come JPEG
Città #
Ashburn 662
Singapore 624
Moscow 526
Hong Kong 525
Dallas 464
San Jose 457
Shanghai 326
Milan 313
Beijing 279
Council Bluffs 215
Hefei 199
New York 199
Princeton 184
Lawrence 183
Lauterbourg 179
Ho Chi Minh City 154
Phoenix 127
Rome 109
São Paulo 99
Hanoi 95
Los Angeles 92
Santa Clara 92
Helsinki 78
Boardman 53
Munich 46
Rio de Janeiro 36
Denver 34
Atlanta 33
London 33
Orem 33
Montreal 32
Nuremberg 32
Warsaw 32
North Bergen 31
Naples 29
Toronto 29
Brooklyn 27
Tokyo 27
Miano 26
Seattle 25
Turin 25
Belo Horizonte 24
Bologna 24
Guangzhou 22
Mexico City 22
Poplar 21
San José 21
Dublin 20
Frankfurt am Main 20
Boston 19
Florence 19
Cagliari 18
Chennai 18
Houston 18
Bari 17
Vienna 17
Da Nang 16
Genoa 16
Haiphong 16
Brasília 15
Stockholm 15
Baghdad 14
Cesano Boscone 14
Johannesburg 14
Ankara 13
Bogotá 13
Chicago 13
Manaus 13
Amsterdam 12
Mapello 12
Quito 12
San Francisco 12
Buffalo 11
Figino 11
Kingston 11
Kuala Lumpur 11
Pavia 11
Pescara 11
Porto Alegre 11
Turku 11
Verona 11
Bergamo 10
Biên Hòa 10
Curitiba 10
Guarulhos 10
Guatemala City 10
Nairobi 10
Rovigo 10
Salvador 10
San Salvador 10
Tashkent 10
Wollongong 10
Xi'an 10
Asunción 9
Brescia 9
Cape Town 9
Galliate 9
Guayaquil 9
Jakarta 9
Jiaxing 9
Totale 7.566
Salva come PNG Salva come JPEG
Nome #
Outcomes of non-invasive ventilation as the ceiling of treatment in patients with COVID-19 419
PACHIMENINGITE IPERTROFICA IGG4-CORRELATA: DIAGNOSI E RISPOSTA TERAPEUTICA 388
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 222
IgG4-Related Midline Destructive Lesion: Expanding the spectrum of organ involvement in IgG4-related disease 201
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 195
IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients 189
A subset of CD4+CD8α- Cytotoxic T cells is expanded in patients with IgG4-Related type 1 autoimmune pancreatitis and decreases with glucocorticoid treatment 188
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study 165
ABS0671 IgG4-RELATED DISEASE IN OVERLAP WITH IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE: CLINICAL-PATHOLOGICAL CHARACTERISTICS AND THERAPEUTIC IMPLICATIONS OF AN ORPHAN DISEASE 162
A CD8α− Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid Treatment 152
A cd8 alpha-negative subset of cd4+slamf7+ cytotoxic t cells is expanded in patients with igg4-related disease and decreases following glucocorticoid treatment 148
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 145
Dupilumab as a potential steroid-sparing treatment for IgG4-related disease. 141
Incidence of endocrine and exocrine insufficiency in patients with autoimmune pancreatitis at diagnosis and after treatment: a systematic review and meta-analysis 138
B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease. 129
B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma 126
Urgent manifestations of immunoglobulin G4-related disease 125
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine 125
Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes 121
ASSOCIAZIONE TRA MALATTIA IGG4-CORRELATA E IMMUNOTERAPIA ALLERGENE-SPECIFICA. STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO. 121
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 119
Advances in the diagnosis and management of IgG4 related disease. 117
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 116
Differential EUS findings in focal type 1 autoimmune pancreatitis and pancreatic cancer: A proof-of-concept study 116
Analisi delle sottopopolazioni T linfocitarie su sangue periferico dei pazienti affetti da malattia IgG4 correlata: aspetti patogenetici e risposta alla terapia con rituximab 116
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation 112
CLINICAL PHENOTYPES OF IGG4- RELATED DISEASE REFLECT DIFFERENCES IN EPIDEMIOLOGICAL FEATURES, SEROLOGICAL FINDINGS,AND PROGNOSTIC OUTCOMES 110
Utility of the “2019 ACR/EULAR classification criteria” for the management of patients with IgG4-related disease 109
Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: A case report and review of the literature. 108
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease 108
IgG4-related pachymeningitis: evidence of intrathecal IgG4 on cerebrospinal fluid analysis. 107
Interleukin 1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study 105
Are atopy and eosinophilic bronchial inflammation associated with relapsing forms of chronic rhinosinusitis with nasal polyps? 103
A unique case of IgG4-related pachymeningitis treated with intrathecal rituximab 103
Effects Of Glucocorticoids On B Cell Subpopulations In Patients With IgG4-Related type I autoimmune pancreatitis 103
Lymphadenopathy in the rheumatology practice: a pragmatic approach 102
ANTIAPOPTOTIC AND IMMUNOMODULATORY EFFECTS OF INTERLEUKIN 7 IN AN EX VIVO MODEL OF HUMAN LYMPHOID TISSUE 102
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease 101
CIRCULATING PLASMABLASTS LEVELS REFLECT INFLAMMATORY ACTIVITY IN IGG4-RELATED DISEASE LESIONS AS ASSESSED BY QUANTITATIVE POSITRON EMISSION TOMOGRAPHY 101
Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: A European multi-centre study 100
ALLERGIC PROFILE AND ALLERGENSPECIFIC IMMUNOTHERAPY IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A SINGLE CENTER OBSERVATIONAL STUDY 99
"How I manage" IgG4-Related Disease 99
Correspondence on 'Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort' 98
Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease 98
European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations. 98
Clinical and dermoscopic features of Castelman's disease: insights from an emblematic case 98
CLINICAL MANIFESTATIONS OF IGG4-RELATED DISEASE ONSET REQUIRE ADMISSION TO THE EMERGENCY DEPARTMENT IN THE MAJORITY OF CASES. EXPERIENCE FROM A SINGLE ITALIAN REFERRAL CENTRE 95
EUS-guided ablation with the HybridTherm Probe as second-line treatment in patients with locally advanced pancreatic ductal adenocarcinoma: A case-control study 94
INFLAMMATORY ACTIVITY OF IgG4-RELATED DISEASE LESIONS ASSESSED BY QUANTITATIVE POSITRON EMISSION TOMOGRAPHY CORRELATES WITH CIRCULATING PLASMABLASTS LEVELS 94
B LYMPHOCYTES DIRECTLY CONTRIBUTE TO TISSUE FIBROSIS IN IGG4-RELATED DISEASE 94
Atypical presentation of Churg-Strauss syndrome or an undescribed hypereosinophilic disease? 93
EFFECTS OF GLUCOCORTICOIDS AND METHOTREXATE-BASED THERAPEUTIC REGIMENS ON B CELL SUBPOPULATIONS IN PATIENTS WITH IGG4-RELATED DISEASE 92
IGG4 RELATED HYPERTROPHIC PACHYMENINGITIS: DIAGNOSTIC APPROACH AND THERAPEUTIC OUTCOMES 92
IDENTIFICAZIONE DI UNA SOTTOPOPOLAZIONE CD8- DI LINFOCITI CD4 CITOTOSSICI ESPANSA NEI PAZIENTI CON MALATTIA IGG4-CORRELATA E RESPONSIVA ALLA TERAPIA CON GLUCOCORTICOIDI 92
Salivary Gland Disease in IgG4-Related Disease is Associated with Allergic Conditions 92
B cells orchestrate tissue fibrosis in IgG4-Related Disease 92
MALATTIA IGG4-CORRELATA: ESPERIENZA QUINQUENNALE MONOCENTRICA SU UNA CORTE ITALIANA DI 150 PAZIENTI (2013 - 2018) 91
IMMUNOTERAPIA SPECIFICA E MALATTIA IgG4-CORRELATA: STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO 91
Deconstructing IgG4-related disease involvement of midline structures: Comparison to common mimickers. 90
MAVRILIMUMAB IMPROVES OUTCOMES IN SEVERE COVID-19 PNEUMONIA AND SYSTEMIC HYPERINFLAMMATION 90
Cerebrospinal fluid analysis in immunoglobulin G4-related hypertrophic pachymeningitis 88
An International, Multi-Specialty Validation Study of the IgG4-Related Disease Responder Index 88
25. Epinephrine autoinjector prescription in food-allergic adults: symptom-based only or allergen-based also? An Italian multi-centre study. 87
Methotrexate as induction of remission therapy for localized manifestations of IgG4-Related Disease. 86
Artrite reumatoide. Dottore mi spieghi meglio 86
CLINICAL PHENOTYPES OF IGG4-RELATED DISEASE REFLECT DIFFERENCES IN EPIDEMIOLOGICAL, IMMUNOLOGICAL AND PROGNOSTIC FEATURES 85
Atopia e malattia IgG4-correlata: relazione casuale o causale? 84
Efficacy of Siltuximab and 1,927 nm Fractional Laser for the Treatment of Cutaneous Manifestations in Castleman's Disease: The Role of Dermoscopy and Reflectance Confocal Microscopy for Lesion Evaluation 83
EFFICACY OF LONG-TERM TREATMENT WITH BIOLOGIC AGENTS IN REFRACTORY ADULT ONSET STILL’S DISEASE: A SINGLE CENTRE EXPERIENCE ON 16 PATIENTS 83
Targeting IL-1, IL-6 or GM-CSF in COVID-19. Response to: 'More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia' by Ferraccioli 82
IgG4-RELATED DISEASE PRESENTATION REQUIRES ADMISSION TO THE EMERGENCY DEPARTMENT IN THE MAJORITY OF CASES 79
Impact of sarilumab on mechanical ventilation in patients with COVID-19. Response to: 'Correspondence on: 'Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation-an open-label cohort study' by Della-Torre et al ' by Cheng and Zhang 78
MERTK AND THE RESOLUTION OF INFLAMMATION IN IGG4-RELATED DISEASE 78
EpidemAAITO: features of food allergy in Italian adults attending allergy clinics: a multi-centre study 78
Systemic lupus erythematosus and COVID-19: what we know so far 77
LONG-TERM EFFICACY OF RITUXIMAB MAINTENANCE THERAPY FOR IGG4- RELATED DISEASE RITUXIMAB MAINTENANCE THERAPY IN IGG4-RELATED DISEASE 77
METHOTREXATE AS INDUCTION OF REMISSION THERAPY FOR LOCALIZED MANIFESTATIONS OF IGG4-RELATED DISEASE 77
IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment. 77
B LYMPHOCYTES DIRECTLY CONTRIBUTE TO TISSUE FIBROSIS IN IGG4-RELATED AUTOIMMUNE PANCREATITIS 77
CLONAL EXPANSION OF CD4+ CYTOTOXIC T LYMPHOCYTES IN IGG4-RELATED DISEASE 76
B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease. 76
EFFECTS OF COMBINED THERAPY WITH PREDNISONE AND METHOTREXATE ON B CELL SUBPOPULATIONS IN PATIENTS WITH IGG4-RELATED DISEASE 75
Immunomodulatory Effects of Endoscopic Ultrasound-Guided Thermal Ablation in Patients with Pancreatic Ductal Adenocarcinoma 74
INCREASE OF CIRCULATING MEMORY B CELLS AFTER GLUCOCORTICOID-INDUCED REMISSION PREDICTS IGG4-RELATED DISEASE RELAPSE 74
The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. 74
CD4+ and CD8+ cytotoxic T lymphocytes may induce mesenchymal cell apoptosis in IgG4-related disease. 73
Intrathecal rituximab for IgG4-related hypertrophic pachymeningitis 72
Immunology of IgG4-related disease 71
In vivo tests with "Tahini" sauce: new allergenic source to evaluate IgE-mediated hypersensitivity to sesame. 71
Palate perforation differentiates cocaine-induced midline destructive lesions from granulomatosis with polyangiitis 70
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circula-ting plasmablasts in IgG4-related type 1 au-toimmune pancreatitis and other organs 70
B LYMPHOCYTES DIRECTLY CONTRIBUTE TO TISSUE FIBROSIS IN IGG4-RELATED DISEASE 70
HYPERSENSITIVITY REACTIONS TO LOW MOLECULAR WEIGHT HEPARIN IN A PREGNANT WOMAN 70
IgG4-related autoimmune liver disease 69
EFFETTI DEL PREDNISONE SULLE SOTTOPOPOLAZIONI B LINFOCITARIE NEI PAZIENTI CON MALATTIA IgG4-CORRELATA 69
EFFECTS OF COMBINED THERAPY WITH PREDNISONE AND METHOTREXATE ON B CELL SUBPOPULATIONS IN PATIENTS WITH IGG4-RELATED DISEASE 69
Malattia sistemica e colangiopatia IgG4-relata 69
IgG4-Related diseases 68
Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse 67
Side effects from polydioxanone 67
Totale 10.684
Salva come PNG Salva come JPEG
Categoria #
all - tutte 93.918
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.918
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022196 0 0 0 33 6 22 14 23 34 21 23 20
2022/20231.129 455 213 66 8 32 115 62 57 59 14 22 26
2023/2024920 30 62 81 82 49 167 42 89 5 42 92 179
2024/20252.858 351 84 81 76 97 222 352 300 550 329 177 239
2025/20268.382 631 790 689 1.061 631 258 680 560 2.181 446 261 194
2026/20272.399 356 577 517 949 0 0 0 0 0 0 0 0
Totale 16.085